The "MERS Middle East Respiratory Syndrome UpEORF1a and ORF1b Multiplex Detection and Differentiation RNA Detection Qualitative Test" is a sophisticated diagnostic tool used to identify and differentiate the RNA of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in patients. This test specifically targets the upstream EORF1a and ORF1b regions of the virus's genome, employing a multiplex approach that allows for the simultaneous detection of both genetic markers. This method ensures a high level of accuracy and specificity in diagnosing MERS-CoV, which is crucial for timely patient management and containment of the virus spread.
The test is conducted at DNA Labs UAE, a leading facility in the field of molecular diagnostics and genetic testing. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experts in virology and molecular biology, ensuring reliable and accurate test results.
The cost of the test is set at 2310 AED, reflecting the complexity of the technology used and the expertise required to perform the analysis. Despite the cost, the test provides critical information for the effective treatment and control of MERS, a potentially deadly respiratory illness that has been a significant health concern in the Middle East and beyond.
The PML/RARA Quantitative Test is a specialized diagnostic procedure aimed at detecting the PML/RARA fusion gene, which is primarily associated with Acute Promyelocytic Leukemia (APL), a subtype of acute myeloid leukemia. This test is crucial for the diagnosis, prognosis, and monitoring of treatment response in patients with APL. Utilizing advanced molecular techniques, the test quantifies the presence of the PML/RARA gene rearrangement, providing essential information for tailored treatment strategies.
Conducted at DNA Labs UAE, a reputable facility known for its state-of-the-art technology and expert staff, the test ensures high accuracy and reliability. The cost of the PML/RARA Quantitative Test at DNA Labs UAE is set at 2310 AED. This investment is pivotal for patients requiring precise diagnosis and monitoring, offering critical insights that guide effective treatment plans and contribute to improved patient outcomes in the battle against Acute Promyelocytic Leukemia.
The "Parainfluenza 1234 Multiplex Detection and Differentiation Quantitative Test" is an advanced diagnostic procedure offered by DNA Labs UAE, designed to accurately identify and differentiate between the four types of human parainfluenza viruses (HPIVs). These viruses are significant pathogens that cause a variety of respiratory illnesses, from mild colds to severe pneumonia and bronchitis, particularly in children, the elderly, and immunocompromised individuals.
Utilizing cutting-edge multiplex PCR technology, this test simultaneously amplifies and detects specific genetic markers for each of the HPIV types - 1, 2, 3, and 4. This allows for a comprehensive analysis in a single assay, providing not only a confirmation of the presence of the virus but also identifying the specific type, which is crucial for appropriate clinical management and treatment strategies.
The cost of the test is set at 2310 AED, reflecting the sophisticated technology and the detailed, valuable insights it offers into the patient's viral infection status. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test represents a significant advancement in the field of infectious disease diagnostics, offering rapid, accurate, and differentiated results that can significantly impact patient care and infection control measures.
The RARAPML Quantitative Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to quantitatively measure the RARAPML gene's expression levels. This test is particularly significant in the field of medical genetics and oncology, providing crucial information that assists in the diagnosis, prognosis, and treatment planning for certain types of cancers, including acute myeloid leukemia (AML). By accurately quantifying the RARAPML gene expression, healthcare professionals can make more informed decisions regarding patient care. The test is conducted using advanced molecular techniques, ensuring precise and reliable results. The cost for undergoing the RARAPML Quantitative Test at DNA Labs UAE is 2310 AED, reflecting the sophisticated nature of the technology and expertise required to perform the analysis.
The RSV A and RSV B Viral Load Quantitative Test is a diagnostic assessment offered by DNA Labs UAE, designed to accurately measure the amount of Respiratory Syncytial Virus (RSV) types A and B in a patient's blood. RSV is a common respiratory virus that causes infections in the lungs and respiratory tract, and it can be particularly severe in infants, young children, and the elderly. The quantitative nature of this test allows healthcare providers to determine the viral load, which can be crucial for assessing the severity of the infection, monitoring the course of the disease, and guiding treatment decisions.
The test involves collecting a sample from the patient, which is then analyzed using sophisticated laboratory techniques to quantify the amount of RSV genetic material present. This level of detail helps in understanding the progression of the infection and can be vital in high-risk cases where tailored treatment plans are necessary.
At DNA Labs UAE, the cost of the RSV A and RSV B Viral Load Quantitative Test is set at 2310 AED. This price reflects the advanced technology and expertise required to perform this specialized diagnostic test. By providing this service, DNA Labs UAE plays a crucial role in the timely and accurate diagnosis of RSV infections, contributing to better patient outcomes through precise and personalized care.
The Zika Virus Viral Load Quantitative Test is a sophisticated diagnostic tool utilized to measure the amount of Zika virus RNA present in a patient's blood. This test is crucial for identifying and managing Zika virus infections, particularly in pregnant women, due to the virus's potential to cause severe birth defects such as microcephaly and other congenital anomalies. By quantifying the viral load, healthcare providers can assess the severity of the infection and monitor the effectiveness of treatment strategies.
Performed at DNA Labs UAE, a leading laboratory known for its advanced diagnostic services, the test employs cutting-edge molecular techniques to ensure accurate and reliable results. The cost of the Zika Virus Viral Load Quantitative Test at DNA Labs UAE is 2310 AED. This investment is vital for those at risk or showing symptoms of Zika virus infection, as it provides essential information for timely and appropriate medical intervention.
The PTHrP (Parathyroid Hormone-related Protein) Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to measure the levels of PTHrP in the blood. This protein plays a crucial role in regulating calcium levels within the body, similar to the parathyroid hormone (PTH). Abnormal levels of PTHrP can indicate various medical conditions, including certain types of cancers, benign tumors, and issues related to calcium metabolism. The test is particularly significant in diagnosing and managing conditions such as hypercalcemia of malignancy, where elevated calcium levels are a result of cancer. The cost for undergoing the PTHrP Test at DNA Labs UAE is 2310 AED, offering patients access to crucial diagnostic information that aids in the effective management and treatment of conditions associated with abnormal PTHrP levels.
Hemophilia A is a genetic disorder characterized by a deficiency in the factor VIII clotting factor, leading to excessive bleeding. Carrier detection tests for Hemophilia A are crucial for identifying individuals who carry the defective gene, even if they do not exhibit symptoms of the disorder themselves. These carriers, often female, have a 50% chance of passing the gene to their offspring, making the detection vital for family planning and management of the condition.
DNA Labs UAE offers a comprehensive Hemophilia A Carrier Detection Test, aimed at identifying the presence of the genetic mutation associated with Hemophilia A. The test is conducted using advanced genetic analysis techniques to examine the specific gene known to cause the disorder. It provides families with the necessary information to understand their genetic risk and make informed decisions regarding their health and the health of future generations.
The cost of the Hemophilia A Carrier Detection Test at DNA Labs UAE is 2450 AED. The test is a valuable resource for those with a family history of Hemophilia A, offering peace of mind and the opportunity to seek early intervention and support if needed. With a commitment to accuracy and confidentiality, DNA Labs UAE ensures that individuals receive comprehensive counseling and support throughout the testing process.
The Interleukin-6 (IL-6) Extended Panel Test is a sophisticated diagnostic procedure available at DNA Labs UAE, designed to measure the levels of IL-6 in the blood. IL-6 is a cytokine, a type of protein important for immune responses, which plays a crucial role in inflammation and the maturation of B cells, among other functions. Elevated levels of IL-6 are associated with various inflammatory and autoimmune conditions, such as rheumatoid arthritis, systemic lupus erythematosus, and certain types of cancers.
This test is particularly useful for healthcare providers to diagnose, monitor the progression, and manage treatment of diseases related to abnormal IL-6 levels. The cost of the IL-6 Extended Panel Test at DNA Labs UAE is 2430 AED. Conducted in a state-of-the-art facility, this test offers a comprehensive analysis, providing essential insights into a patient's inflammatory status and immune function, aiding in the delivery of personalized medical care.
Minimal Residual Disease (MRD) Analysis for B-Cell Acute Lymphoblastic Leukemia (B-ALL) is a highly sensitive diagnostic test performed to detect the minute levels of cancer cells that remain in a patient's body during or after treatment, which are not detectable using conventional methods. This test is crucial for assessing the effectiveness of leukemia treatment, determining remission status, and guiding further therapeutic decisions to prevent relapse.
At DNA Labs UAE, the MRD Analysis for B-ALL employs cutting-edge molecular and cytogenetic techniques to identify and quantify residual leukemia cells with exceptional accuracy. This allows healthcare providers to tailor treatment plans to the individual patient's needs, potentially increasing the chances of successful outcomes.
The cost of the MRD Analysis for B-ALL test at DNA Labs UAE is 2430 AED. This investment in health provides invaluable information for managing and monitoring B-ALL, contributing significantly to personalized patient care and optimized treatment strategies.
